Thursday, July 02, 2020 7:14:55 AM
I extrapolated a short term share price using Mr. Carmelo's own projected market cap from Revives website above.
His market cap for phase 3 covid testing was 1.1 billion. If you divide that by 156M outstanding shares, the share price should be $6.87. Also, comparing this company sp with cydy and it's outstanding shares, a future sp is approx $17. It feels good to say goodbye to covid while retiring again for the 2nd time. LOL
His market cap for phase 3 covid testing was 1.1 billion. If you divide that by 156M outstanding shares, the share price should be $6.87. Also, comparing this company sp with cydy and it's outstanding shares, a future sp is approx $17. It feels good to say goodbye to covid while retiring again for the 2nd time. LOL
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
